The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumQuick Picks - After Stifel Nicolaus initiated a Buy rating on Geron Corporation (NASDAQ:GERN) Thursday morning, shares are up 10% to $2.68. The $4 target price initially created … Continue Reading
Read nowLong Ideas - Sucampo Pharmaceuticals (NASDAQ:SCMP) announced that the the only holder of its Class B shares had converted them all into Class A common stock on a … Continue Reading
Read nowLong Ideas - On Wednesday, the FDA removed Exelixis’ (NASDAQ:EXEL) lead candidate cabozantinib from the agenda of the Oncology Drugs Advisory Committee (ODAC) meeting in early November, but … Continue Reading
Read nowQuick Picks - Sarepta Therapeutics (NASDAQ:SRPT) is up nearly 13% in pre-market trading on a story highlighting a Duchenne Muscular Dystrophy (DMD) patient’s progress on the company’s development-stage … Continue Reading
Read nowLong Ideas - The CEO of Spectrum Pharmaceuticals (NASDAQ:SPPI) will present today in Southern California at an investor conference (12:00pm EST, webcast available at www.sppirx.com). In addition to … Continue Reading
Read nowQuick Picks - Warner Chilcott (NASDAQ:WCRX) opened down 23% from Tuesday’s closing price of $16.90 after the company announced that the ex-dividend date for its $4 special dividend … Continue Reading
Read nowLong Ideas - A Bloomberg article today illustrates the Street’s bullish outlook on Achillion Pharmaceuticals (NASDAQ:ACHN) as a takeover candidate. Following the failure of Hep C compounds being developed … Continue Reading
Read now
